TGFB1 and obesity disorder: Although it has been well documented that AST can eliminate the detrimental consequences triggered by obesity [38], there is scant evidence about its effects on changes in adipocytokines and myokines including TGF-β1, activin A, MST, FST, and DCN, which have cardinal roles during obesity.